Harrow (NASDAQ: HROW) net income
Harrow reported a net loss of $5.1m for fiscal 2025; in fiscal 2024 it reported a net loss of $17.5m. Earnings per share were −$0.14.
Harrow's best year of the last 10 was fiscal 2018. The biggest drop was in fiscal 2019, −98.9%. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$5.1m | — | −1.9% | −$0.14 |
| 2024 | −$17.5m | — | −8.8% | −$0.49 |
| 2023 | −$24.4m | — | −18.7% | −$0.75 |
| 2022 | −$14.1m | — | −15.9% | −$0.51 |
| 2021 | −$18.0m | — | −24.8% | −$0.69 |
| 2020 | −$3.4m | −2,098.2% | −6.9% | −$0.13 |
| 2019 | $0.2m | −98.9% | 0.3% | $0.01 |
| 2018 | $14.6m | — | 35.3% | $0.67 |
| 2017 | −$12.0m | — | −44.8% | −$0.60 |
| 2016 | −$19.1m | — | −95.7% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Harrow net income compared with its sector
By net income for its latest fiscal year, Harrow ranks 182nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Harrow, −1.9%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 180th | BioLife Solutions | −$4.6m | −4.8% |
| 181st | ETON Pharmaceuticals | −$4.6m | −5.8% |
| 182nd | Harrow | −$5.1m | −1.9% |
| 183rd | Akebia Therapeutics | −$5.3m | −2.3% |
| 184th | Assembly Biosciences | −$6.1m | −8.5% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Harrow
- How much did Harrow earn in fiscal 2025?
- Harrow reported a net loss of $5.1m for fiscal 2025. In fiscal 2024 it reported a net loss of $17.5m.
- What are the earnings per share of Harrow?
- They were −$0.14 in fiscal 2025, compared with −$0.49 in fiscal 2024.
- What was the most profitable year for Harrow?
- Of its last 10 fiscal years, fiscal 2018, with $14.6m.
- Where does Harrow rank in its sector by net income?
- It ranks 182nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Harrow come from?
- From the annual report (Form 10-K) that Harrow files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Harrow files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Harrow: the Harrow page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.